AGÕæÈ˹ٷ½

STOCK TITAN

[SCHEDULE 13G/A] Atossa Therapeutics, Inc. SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A





Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)






SCHEDULE 13G





SCHEDULE 13G



The Vanguard Group
Signature:Ashley Grim
Name/Title:Head of Global Fund Administration
Date:07/29/2025
Atossa Therapeutics Inc

NASDAQ:ATOS

ATOS Rankings

ATOS Latest News

ATOS Latest SEC Filings

ATOS Stock Data

100.15M
129.08M
0.07%
21.17%
2.95%
Biotechnology
Pharmaceutical Preparations
United States
SEATTLE